strength ahead ingeniorx launch
continu oper momentum management continu highlight compani
strong oper momentum also acknowledg pocket pressur
medicaid commerci side strong risk-bas membership gain repres
notic improv mute result follow beat-and-
rais morn increas ep estim
increas ep estim earn season
ep alreadi consensu prior today result lower
ep reflect higher start-up cost relat ingeniorx
ep estim reflect growth y/i ep repres slightli
less full year estim color pg note
govern busi higher-than-expect attribut
significantli lower out-of-period medicaid revenu current quarter elev cost
pressur select state dilut new group busi despit
medicar medicaid oper within target margin previous disclos
follow unh recent decis exit iowa medicaid program
management assur investor work state ensur appropri
membership alloc actuari sound rate reflect acuiti
underli popul serv take closer look iowa plan perform pg
reiter ow view remain attract growth stori multi-year
earn visibl driven may launch new pbm see ep bridg figur
management also remain optimist commerci growth prospect fuel
pharmaci cost save ingeniorx reiter ow rate increas pt
base price-to-earnings new ep estim
quarterli annual ep usd
rais usd
return equiti ttm
link barclay live interact chart
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
overweight remain attract
growth stori multi-year earn visibl driven
launch new pbm ingeniorx
supplement opportun acceler
growth nearli everi aspect enterpris
includ commerci specialti group
medicar advantag high-acu medicaid
upsid case reflect increas earn visibl
new pbm contract higher expect
downsid case reflect risk associ
increas cost trend aggress commerci price
lower expect medicar growth lower
visibl earn new pbm contract
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
releas initi guidanc februari compani cite improv
medicaid perform tailwind help off-set margin normal individu
busi view iowa state may improv meaning given
strong rate increas howev elev medic cost select state continu
weigh govern result unh recent decis exit iowa effect june
call question sustain iowa program
antm margin perform trend much better recent quarter
yet visibl recent quarterli perform state
absorb meaning membership amerihealth exit iowa
program vast major amerihealth member instead went
depart like need absorb unprofit member
two separ plan struggl manag manag note
continu work state ensur appropri membership alloc
actuari sound rate reflect acuiti underli popul serv
iowa medicaid membership perform
iowa medicaid membership perform
pbm benefit lead strong multi-year earn visibl
 earn guidanceoper revenueapproxim bnapproxim bnpremium bn bn bnbenefit expens /- /- bpscost product bn bn bnsg /- /- bpsoper gaingreat bngreater bnnet invest bninterest mnamort mneffect tax epsgreat epsgreat mnoper flowgreat bngreater bnshare bilcost /- /- bpsmembership insur medic membership benefitback-end weightedback-end weightedseasonalityslighti half earn half earn barclay
inc annual incom statement mil ep compon oper invest loss oper invest medic loss oper expens ex one-tim oper addback oper incom oper oper tax rate minor interest oper check fulli dilut share barclay
inc quarterli incom statement mil ep ep ep ep compon oper invest loss nm nm total oper invest medic loss expens ex one-tim oper addback oper incom oper rate minor interest check fulli dilut share barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
procedur pleas
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
price sourc refinitiv last avail close price relev trade market unless anoth time sourc indic
